Integrin inhibitors for the treatment of eye diseases

Details Integrin inhibitors for the treatment of eye diseases Integrin inhibitors for the treatment of eye diseases

A - Human Necessities

61

K

A61K 31/405 (2006.01) A61K 31/335 (2006.01) A61K 31/35 (2006.01) A61K 31/351 (2006.01) A61K 31/38 (2006.01) A61K 31/395 (2006.01) A61K 38/12 (2006.01)

Patent

CA 2456076

Methods and compositions for prophylaxis and/or treatment of diseases of the eye using antagonists of the integin receptors .alpha.v.beta.3 and/or .alpha.v.beta.5. The compositions can be nanoparticles and are administered to the eye by injection into the vitreous body of the eye.

L'invention concerne des procédés et des compositions pour la prophylaxie et/ou le traitement de maladies des yeux, ces compositions contenant des antagonistes des récepteurs de l'intégrine .alpha.¿v?.beta.¿3?/ou .alpha.¿v?.beta.¿5?. Lesdites compositions peuvent être des nanoparticules et sont administrées par injection dans le corps vitreux de l'oeil.

Affiliated with

Also associated with

Rating

Integrin inhibitors for the treatment of eye diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Integrin inhibitors for the treatment of eye diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Integrin inhibitors for the treatment of eye diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1464524